Matthew B. Casale

FDA investigator · also recorded as On Eee Matthew Casale

Appears on 29 documents from 2015 to 2026, most often at sites in Ohio. Most often cites design and construction features (21 CFR 211.42).

29
Documents on file
4.4
Observations per 483
2015
First seen
2026
Most recent

What they cite most

From 123 observations

Activity by year

2015: 3, 2016: 3, 2017: 3, 2018: 4, 2019: 3, 2021: 1, 2022: 4, 2023: 1, 2024: 2, 2025: 3, 2026: 2

Where

Ohio 9 · Japan 4 · India 3 · South Korea 2 · Switzerland 2 · California 1

Is Matthew B. Casale coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

29 documents, newest first
FirmOpen
483 Alvotech HFMay 8, 2026 · Reykjavik, Iceland
483 EUGIA Pharma Specialities LimitedFeb 27, 2026 · Medchal-Malkajgiri District, India
483 ASANUMA CORPORATIONFeb 28, 2025 · SAGAMIHARA, Japan
483 Ajinomoto Company, Inc.Feb 21, 2025 · Kawasaki, Japan
483 Ajinomoto Company Inc. Kawasaki Plant. 1-1 Suzuki -Cho. Kawasaki -KuFeb 21, 2025 · Kawasaki -City. Kanagawa, Japan
483 Chemblend of America LLCJun 7, 2024 · Bensenville, Illinois
483 Steri-Med Pharma Inc.Feb 27, 2024 · Upton, Canada

About this profile

What does Matthew B. Casale inspect?

Matthew B. Casale appears on 29 documents on file covering 26 sites, most often in Ohio.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Matthew B. Casale is dated May 8, 2026.

FDA Investigator Matthew B. Casale: 483s & Inspections · FDA Intel